NCT06114615 Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
| NCT ID | NCT06114615 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Coronary Artery Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to support patients immediately after percutaneous coronary intervention (PCI) by implementing a telemonitoring program. Eligible patients have coronary heart disease and undergo PCI. The intervention group receives remote monitoring and text-based follow-up, with established health goals and education on using the telemonitoring application, along with necessary devices. The control group gets standard care. Outcomes measured include blood pressure, LDL levels, patient satisfaction, revascularization, and mortality. The study findings will enhance patient care after PCI and contribute evidence for widespread telemonitoring implementation in healthcare systems, aiding medical therapy and lifestyle modifications.
Eligibility Criteria
Inclusion Criteria: * Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at University of California Davis Health.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06114615 clinical trial?
This trial is open to participants of all sexes, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06114615 currently recruiting?
Yes, NCT06114615 is actively recruiting participants. Contact the research team at smatreja@ucdavis.edu for enrollment information.
Where is the NCT06114615 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT06114615 clinical trial?
NCT06114615 is sponsored by University of California, Davis. The trial plans to enroll 200 participants.